Ulm, Univ. Diss., 2006.

Thesis (Ph. D.)--University of Hong Kong, 2009. / Includes bibliographical references (leaves 141-162). Also available in print.

Thesis--Copenhagen University. / Summary in Danish. Includes index. Bibliography: p. 139-162.

Techn. Universiẗat, Diss., 2005--München.

Regensburg, Univ., Diss., 2002.

Boston University. University Professors Program Senior theses. / PLEASE NOTE: Boston University Libraries did not receive an Authorization To Manage form for this thesis. It is therefore not openly accessible, though it may be available by request. If you are the author or principal advisor of this work and would like to request open access for it, please contact us at open-help@bu.edu. Thank you. / 2031-01-02

Renin is the initiator and rate-limiting factor of the renin-angiotensin system, a major mechanism of blood pressure regulation. The synthesis and secretion of this active circulatory enzyme is confined exclusively to the dense core granules of kidney juxtaglomerular (JG) cells where its precursor prorenin is packaged, cleaved to the active form and stored for release on a regulated pathway. Given its importance, surprisingly little is known about this process, in part due to the difficulty in culturing primary JG cells in vitro and the lack of reliable cell lines. The initial aim of the current work was to investigate renin-containing granule dynamics in live JG cells. To achieve this, I attempted to derive novel cell lines from triple transgenic mouse models comprising immortalised granulated or non-granulated JG cells. Due to the nature of JG cells in culture, the use of these cell lines to investigate granulation was not feasible; therefore the culture of primary JG cell culture was modified and enhanced to visualise granule dynamics in live, primary JG cells for the first time. By isolating cells using a Percoll gradient and plating them on fibronectin-coated dishes, rapid and full adhesion of JG cells was achieved, as well as prolonged expression of renin from 3 days to up to 8 days post-isolation. Using this protocol to isolate JG cells from RenGFP renin reporter mice and identifying granules using the acidotropic fluorophore Lysotracker, granule dynamics were investigated in primary JG cells. High resolution, rapid image acquisition was performed using widefield and total internal reflection microscopy, showing that dense core granules respond dynamically to the β-adrenergic agonist isoproterenol, a known renin secretory stimulus. Two different pools of granules of varying granule diameters and dynamic parameters were identified optically, suggesting that separate granule pools were being identified. Mice null for the Ren-1d gene lack renin storage granules in their JG cells, however granulation was restored in Ren1d-null mice carrying a transgene encompassing the human renin (hRen) locus. Therefore in order to investigate the relationship between renin expression and the amount of granulation in JG cells, mice expressing human renin were used. To dissect the granulation phenotype in detail, 2D electron micrographs were taken of JG cells, which were immunogold stained to confirm renin content, and reconstructed in 3D. Female hRen mice showed a significantly higher volume of granulation and an increased granule number compared to males, a finding consistent with the sexually dimorphic expression of the transgene, supporting the hypothesis that granulation in JG cells is dependent on the level of renin expression. The macula densa (MD) is a critical sensor of flow and salt content in the blood; through extensive tubulo-vascular crosstalk known as tubuloglomerular feedback (TGF), it releases key signalling factors stimulating and inhibiting renin synthesis and secretion from JG cells. Ren-1d-/- mice showed a hypercellular and columnar MD plaque, which was not restored by the introduction of the hRen transgene, indicating that TGF may be impaired in these mice. Using an isolated, perfused juxtaglomerular apparatus model it was shown that high salt- and increased flow-induced TGF functioned effectively in Ren1d-/- and huRen+/-Ren1d-/- mice, although animals on a Ren1d-/- background showed decreased sensitivity of glomerular tuft contraction and abnormal calcium signalling within macula densa cells. In conclusion, an appropriate in vitro model was developed for investigating granule dynamics in JG cells, using which granule motion was visualised and quantified for the first time in these cells. Although JG cell granulation is required for normal MD morphology, it was shown to not affect JGA function.

The occurrence of a functional intracellular renin-angiotensin system (RAS) has emerged as a new paradigm. Recently, we and others demonstrated intracellular synthesis of ANG II in cardiac myocytes and vascular smooth muscle cells that was dramatically stimulated in high glucose conditions. Cardiac fibroblasts significantly contribute to diabetes-induced diastolic dysfunction. The objective of the present study was to determine the existence of the intracellular RAS in cardiac fibroblasts and its role in extracellular matrix deposition. Neonatal rat ventricular fibroblasts were serum starved and exposed to isoproterenol or high glucose in the absence or presence of candesartan, which was used to prevent receptor-mediated uptake of ANG II. Under these conditions, an increase in ANG II levels in the cell lysate represented intracellular synthesis. Both isoproterenol and high glucose significantly increased intracellular ANG II levels. Confocal microscopy revealed perinuclear and nuclear distribution of intracellular ANG II. Consistent with intracellular synthesis, Western analysis showed increased intracellular levels of renin following stimulation with isoproterenol and high glucose. ANG II synthesis was catalyzed by renin and angiotensin-converting enzyme (ACE), but not chymase, as determined using specific inhibitors. High glucose resulted in increased transforming growth factor-β and collagen-1 synthesis by cardiac fibroblasts that was partially inhibited by candesartan but completely prevented by renin and ACE inhibitors. In conclusion, cardiac fibroblasts contain a functional intracellular RAS that participates in extracellular matrix formation in high glucose conditions, an observation that may be helpful in developing an appropriate therapeutic strategy in diabetic conditions.

Currently, it is reported that ~65% and 34% of the U.S. population is overweight and obese, respectively. Obesity is a major risk factor for cardiovascular disease. Overweight and obese individuals are also at an increased risk of developing hypertension. Whole-body insulin sensitivity is reduced in obesity, resulting in insulin resistance and increased risk of type 2 diabetes. One possible mechanism contributing to insulin resistance in obesity hypertension is renin-angiotensin system (RAS) overactivation. The RAS exhibits vasocontricting and sodium-retaining properties, yet in vivo and in vitro animal experiments suggest impairment of whole-body insulin sensitivity with increased angiotensin II (Ang II) exposure. Furthermore, evidence from clinical studies indicates Ang II receptor blockers (ARBs) may reduce the incidence of new-onset diabetes compared to other antihypertensive agents in at-risk hypertensive patients. However, it is unclear if whole-body insulin sensitivity is improved with Ang II receptor blockade in humans. Thus, we tested the hypothesis that 8-week Ang II receptor blockade with olmesartan would improve whole-body insulin sensitivity in overweight and obese individuals with elevated blood pressure (BP). Olmesartan was selected for the present study because it is devoid of partial PPARγ agonist activity. To test our hypothesis, intravenous glucose tolerance tests were performed to measure insulin sensitivity before and after control and ARB treatment in a randomized crossover manner. Because skeletal muscle tissue accounts for ~75-90% of insulin-stimulated glucose uptake, a secondary exploratory aim was to examine skeletal muscle inflammatory and collagen response in relation to insulin sensitivity during ARB treatment. No baseline differences were observed between treatments (P>0.05). Both systolic (-11.7 mmHg; P=0.008) and diastolic (-12.1 mmHg; P=0.000) BP were reduced with ARB treatment. Insulin sensitivity was not different between treatments (P>0.05). No correlates of insulin sensitivity were identified. In addition, skeletal muscle inflammatory and collagen gene expression did not change from pre- to post-ARB treatment (P>0.05). Our findings suggest that short-term RAS blockade in overweight and obese adults with elevated BP does not improve whole-body insulin sensitivity, despite a significant BP reduction. Further studies are needed to clarify the role of individual RAS blockers on insulin sensitivity during RAS inhibition in obesity hypertension. / Ph. D.

Die mittlere Höhe des arteriellen Blutdruckes (AP) ist von zentraler Bedeutung für das kardiovaskuläre Risiko Hochdruckkranker. Zusätzlich zeigen neuere Untersuchungen, daß Änderungen der Blutdruckdynamik eine wichtige Rolle in der Entwicklung hypertonieassoziierten Endorganschäden zukommt. Die Blutdruckvariabilität scheint in diesem Zusammenhang sogar einen eigenständigen Risikofaktor zu bilden. Der Einfluß kurzfristiger Blutdruckschwankungen auf zentrale Mechanismen der Langzeitblutdruckregulation, wie beispielsweise die renale Elimination von Natrium und Wasser, ist weitgehend unbekannt. Unsere Untersuchungen zeigen, daß schnelle Blutdruckschwankungen (BPO) kaum von der renalen Autoregulation der Durchblutung (RBF) unterdrückt werden können und zu Oszillation im Harnzeitvolumen führen. Es ist daher wahrscheinlich, daß BPO intrarenale System der Blutdruckregulation (wie beispielsweise das Renin-Angiotensin-System oder die schubspannungsabhängige Freisetzung von Stickoxid) modulieren können. Um diese Hypothese zu testen wurde der Einfluß von 0,1Hz BPO auf die Entwicklung eines renovaskulären Hypertonus untersucht. BPO um 85mmHg senkten signifikant die Plasmareninaktivität, erhöhten die tägliche Ausscheidung von Wasser, Natrium und Kalium und induzierten einen transienten Anstieg der Nitratspiegel im Urin wobei eine deutliche Senkung des arteriellen Blutdruckes beobachtet wurde. / The average level of arterial blood pressure (AP) is a major determinant of future cardiovascular complications in hypertension. In addition, recent investigations demonstrate that the dynamic properties of BP are of significant importance for the development of hypertension - related end organ damage in patients. Thus, hypertension - related changes in blood pressure dynamics seem to establish an independent risk factor for cardiovascular complications. Little is known regarding the influence of such short - term changes in AP on kidney function, a crucial control element for long - term AP regulation. Our investigations show that fast blood pressure oscillations (BPO) are not effectively buffered by renal blood flow autoregulation and induce oscillations in urine flow. It seems, therefore, likely that AP fluctuations can modulate intrarenally located systems involved in blood pressure regulation (e.g., renin release or shear stress dependent release of endothelium derived nitric oxide). To test this hypothesis we investigated the impact of induced BPO with a frequency of 0.1Hz on the onset of renovascular hypertension. BPO around 85mmHg significantly decreased plasma renin activity, enhanced 24h fluid, sodium and potassium excretion, and induced a transient increase in urinary nitrate excretion, thereby, attenuating renovascular hypertension.